Innovative Drug Development: Kalydeco Provides A Paradigm, FDA’s Spielberg Says

The deputy commissioner detailed the steps involved in getting Vertex’s cystic fibrosis drug rapidly through the approval process and noted that FDA is working on innovative study designs and assessing how to better use diagnostics.

More from Approvals

More from Product Reviews